Literature DB >> 11689424

Crystal structure of human uroporphyrinogen III synthase.

M A Mathews1, H L Schubert, F G Whitby, K J Alexander, K Schadick, H A Bergonia, J D Phillips, C P Hill.   

Abstract

Uroporphyrinogen III synthase, U3S, the fourth enzyme in the porphyrin biosynthetic pathway, catalyzes cyclization of the linear tetrapyrrole, hydroxymethylbilane, to the macrocyclic uroporphyrino gen III, which is used in several different pathways to form heme, siroheme, chlorophyll, F(430) and vitamin B(12). U3S activity is essential in all organisms, and decreased activity in humans leads to the autosomal recessive disorder congenital erythropoetic porphyria. We have determined the crystal structure of recombinant human U3S at 1.85 A resolution. The protein folds into two alpha/beta domains connected by a beta-ladder. The active site appears to be located between the domains, and variations in relative domain positions observed between crystallographically independent molecules indicates the presence of flexibility that may be important in the catalytic cycle. Possible mechanisms of catalysis were probed by mutating each of the four invariant residues in the protein that have titratable side chains. Additionally, six other highly conserved and titratable side chains were also mutated. In no case, however, did one of these mutations abolish enzyme activity, suggesting that the mechanism does not require acid/base catalysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689424      PMCID: PMC125291          DOI: 10.1093/emboj/20.21.5832

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  22 in total

1.  Congenital erythropoietic porphyria: a novel homozygous mutation in a Japanese patient.

Authors:  T Rogounovitch; N Takamura; I Hombrados; C Morel; T Tanaka; Y Kameyoshi; Y Shimizu-Yoshida; H de Verneuil; S Yamashita
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

Review 2.  Molecular genetics of congenital erythropoietic porphyria.

Authors:  R J Desnick; I A Glass; W Xu; C Solis; K H Astrin
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

3.  Dali/FSSP classification of three-dimensional protein folds.

Authors:  L Holm; C Sander
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

4.  Fast and sensitive multiple sequence alignments on a microcomputer.

Authors:  D G Higgins; P M Sharp
Journal:  Comput Appl Biosci       Date:  1989-04

5.  Congenital erythropoietic porphyria affecting two brothers.

Authors:  A Herrera Saval; A Moruno Tirado
Journal:  Br J Dermatol       Date:  1999-09       Impact factor: 9.302

6.  The discovery of nature's biosynthetic pathways.

Authors:  A R Battersby
Journal:  Experientia       Date:  1978-01-15

7.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

8.  Purification and properties of uroporphyrinogen III synthase from human erythrocytes.

Authors:  S F Tsai; D F Bishop; R J Desnick
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

9.  Congenital erythropoietic porphyria: identification and expression of exonic mutations in the uroporphyrinogen III synthase gene.

Authors:  C A Warner; H W Yoo; A G Roberts; R J Desnick
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

10.  How a protein binds B12: A 3.0 A X-ray structure of B12-binding domains of methionine synthase.

Authors:  C L Drennan; S Huang; J T Drummond; R G Matthews; M L Ludwig
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

View more
  26 in total

1.  Intra-chain 3D segment swapping spawns the evolution of new multidomain protein architectures.

Authors:  András Szilágyi; Yang Zhang; Péter Závodszky
Journal:  J Mol Biol       Date:  2011-11-04       Impact factor: 5.469

Review 2.  Structure and function of enzymes in heme biosynthesis.

Authors:  Gunhild Layer; Joachim Reichelt; Dieter Jahn; Dirk W Heinz
Journal:  Protein Sci       Date:  2010-06       Impact factor: 6.725

Review 3.  Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.

Authors:  Dulmini P Barupala; Stephen P Dzul; Pamela Jo Riggs-Gelasco; Timothy L Stemmler
Journal:  Arch Biochem Biophys       Date:  2016-01-16       Impact factor: 4.013

Review 4.  One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans.

Authors:  Iqbal Hamza; Harry A Dailey
Journal:  Biochim Biophys Acta       Date:  2012-05-08

Review 5.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

6.  Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.

Authors:  Sonia Clavero; David F Bishop; Urs Giger; Mark E Haskins; Robert J Desnick
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

7.  Intracellular rescue of the uroporphyrinogen III synthase activity in enzymes carrying the hotspot mutation C73R.

Authors:  Arola Fortian; Esperanza González; David Castaño; Juan M Falcon-Perez; Oscar Millet
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

8.  Characterization of his-tagged rat uroporphyrinogen III synthase wild-type and variant enzymes.

Authors:  Nan Li; Dik-Lung Ma; Xiaojun Liu; Long Wu; Xiusheng Chu; Kwok-Yin Wong; Ding Li
Journal:  Protein J       Date:  2007-12       Impact factor: 2.371

9.  Quantitative comparison of catalytic mechanisms and overall reactions in convergently evolved enzymes: implications for classification of enzyme function.

Authors:  Daniel E Almonacid; Emmanuel R Yera; John B O Mitchell; Patricia C Babbitt
Journal:  PLoS Comput Biol       Date:  2010-03-12       Impact factor: 4.475

Review 10.  Erythroid heme biosynthesis and its disorders.

Authors:  Harry A Dailey; Peter N Meissner
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.